Israeli Pharmaceutical Industry Worth $2.3 Billion by 2020
“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Israel”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Israel. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research,...
View full press release